West Pharmaceutical Services holds the cleaner structural position, with profitability as the main driver and valuation adding further support. Ipsen does not offset that deficit through any equally strong structural edge elsewhere. In the market, Ipsen carries the stronger setup — intact trend against West Pharmaceutical Services's broken trend. That leaves a split case: the structural lead stays with West Pharmaceutical Services, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels.
Most of the visible separation comes from profitability. West Pharmaceutical Services, Inc. leads by 17 points on the overall comparison score.
These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.
This level of similarity signals a strong structural match, even though some dimensions still separate the two companies.
The match is driven mainly by revenue stability and margin trend.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
Score differences across key dimensions.
Left means cheaper relative valuation. Higher means stronger structure.
Neither company combines the stronger profile with the cheaper valuation.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
Capital efficiency adds support, with a 5.1-point ROIC advantage.
On the market side, Ipsen carries the stronger trend while West Pharmaceutical Services's trend has broken — the market setup does not confirm the structural advantage.
Profitability is the clearest driver, and valuation also supports West Pharmaceutical Services, Inc.'s broader structural position.
Break down the IPN.PA vs WST comparison across all dimensions with the full interactive tool.
Explore how IPN.PA and WST each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.